CHU Nantes, Université de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, Nantes, France.
Labex IGO, Nantes, France.
Methods Mol Biol. 2021;2270:203-216. doi: 10.1007/978-1-0716-1237-8_11.
Granzyme B (GZMB)-expressing B cells inhibit CD4 T-lymphocyte proliferation in a contact- and GZMB-dependent manner, through degradation of TCR zeta or induction of T-cell apoptosis. This regulatory B-cell population is present in human healthy individuals and represents about 1% of circulating B cells. Their small proportion requires the development of expansion methods to enable their study and envision clinical applications. We describe here how to expand GZMB-expressing B cells to obtain more than 90% of highly purified GZMB B cells, and the protocol of B/T cells coculture for the evaluation of the suppressive function of the GZMB B-cell population.
颗粒酶 B(GZMB)表达的 B 细胞通过降解 TCR ζ 或诱导 T 细胞凋亡,以接触依赖和 GZMB 依赖的方式抑制 CD4 T 淋巴细胞的增殖。这种调节性 B 细胞群体存在于人类健康个体中,约占循环 B 细胞的 1%。由于其比例较小,需要开发扩增方法以使其能够进行研究和设想临床应用。我们在此描述如何扩增 GZMB 表达的 B 细胞,以获得超过 90%的高度纯化的 GZMB B 细胞,以及 B/T 细胞共培养的方案,以评估 GZMB B 细胞群体的抑制功能。